Member Info for Mongrels3

LIBERUM RAISES SPIRE HEALTHCARE PRICE TARGET TO 180 (155) PENCE - 'BUY'

JPMORGAN RAISES ROYAL MAIL TO 'OVERWEIGHT' ('NEUTRAL') - TARGET 374 (253) PENCE

GOLDMAN RAISES ROYAL MAIL PRICE TARGET TO 310 (290) PENCE - 'BUY'

Reported in the Smith & Nephew trading update - 'global levels of elective surgery continued to recover'

https://www.sharecast.com/news/broker-recommendations/jpmorgan-upgrades-spire-healthcare-to-overweight--7656049.html

Taken from IG's morning email:

Spire Healthcare raised to overweight at JPMorgan

UBS RAISES ROYAL MAIL PRICE TARGET TO 304 (215) PENCE - 'BUY' (taken from LSE)

Taken from LSE news roundup:

GOLDMAN SACHS RAISES ROYAL MAIL PRICE TARGET TO 290 (230) PENCE - 'BUY'

JP Morgan raises Spire to 1.36

Spire raised to buy today by Peel Hunt. I've bought 8,000 more this morning. Gambling really, but let's see!

Those directors have convinced me to buy this pm. 5 weeks until half year results.

From BBC - 05/12/18

Gerald Khoo, an analyst at Liberum, says the company's valuation is "attractive". "The lowly valuation reflects the challenges, but not the potential for management to address them," he says. He has kept his "buy" recommendation on the shares.

Taylor Wimpey Upgraded to Overweight at Barclays

So DBAY has built a stake of over 26% (and could be higher depending on trades from Friday). I'm surprised that it hasn't risen slightly more on speculation alone. They could be in line to get the whole HVN business very cheaply at this rate.